Cibus Global LLC (CBUS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.615x

Based on the latest financial reports, Cibus Global LLC (CBUS) has a cash flow conversion efficiency ratio of -0.615x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-13.42 Million) by net assets ($21.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cibus Global LLC - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Cibus Global LLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Cibus Global LLC carry for a breakdown of total debt and financial obligations.

Cibus Global LLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cibus Global LLC ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Fulin Plastic Industry Cayman Holding Co Ltd
TW:1341
0.123x
Grupo Ortiz Properties Socimi
MC:YGOP
0.009x
Tillys Inc
NYSE:TLYS
0.101x
Star Holdings
NASDAQ:STHO
-0.030x
Icares Medicus Inc
TWO:6612
-0.042x
Frontier Lithium Inc
V:FL
0.266x
Cantargia AB
ST:CANTA
0.943x
Argent
JSE:ART
0.099x

Annual Cash Flow Conversion Efficiency for Cibus Global LLC (2015–2025)

The table below shows the annual cash flow conversion efficiency of Cibus Global LLC from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Cibus Global LLC market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $21.83 Million $-50.59 Million -2.318x -290.63%
2024-12-31 $97.83 Million $-58.04 Million -0.593x -334.34%
2023-12-31 $338.29 Million $-46.21 Million -0.137x +94.90%
2022-12-31 $7.23 Million $-19.36 Million -2.677x -101.13%
2021-12-31 $14.13 Million $-18.81 Million -1.331x -12.39%
2020-12-31 $36.88 Million $-43.67 Million -1.184x -131.70%
2019-12-31 $62.51 Million $-31.95 Million -0.511x -135.73%
2018-12-31 $93.40 Million $-20.25 Million -0.217x +2.52%
2017-12-31 $57.48 Million $-12.79 Million -0.222x +68.41%
2016-12-31 $13.12 Million $-9.24 Million -0.704x -155.26%
2015-12-31 $24.26 Million $-6.69 Million -0.276x --

About Cibus Global LLC

NASDAQ:CBUS USA Biotechnology
Market Cap
$110.45 Million
Market Cap Rank
#19117 Global
#4203 in USA
Share Price
$1.45
Change (1 day)
+3.57%
52-Week Range
$1.16 - $4.05
All Time High
$1574.00
About

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-th… Read more